Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Within the pharmaceutical arena, the promise of me
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
These days with all of the distractions notificati
Since it’s an ingredient in so many foods, you h
In a world constantly in motion, Microbioz India r
Dr. Hemant R. Jadhav, a BITS Pilani professor, spends his days sketching tiny drug-like shapes on a computer screen and nights watching them grow into real compounds. His work targets cancer, HIV, Alzheimer’s, and diabetes—blending molecular design with hands-on testing to yield future-ready therapies.
At the core of his research are histone demethylases—epigenetic gatekeepers that control disease expression like a lock-and-key system. By combining in-silico predictions with experimental pharmacology, Dr. Jadhav is accelerating the drug discovery timeline.
Despite challenges in solubility, selectivity, and scalability, his multidisciplinary approach paves the way for smarter, more effective treatments.
Come prepared to think differently. This isn’t your usual lecture. Dr. Jadhav’s sharp insights make this a can’t-miss session—especially if you’re invested in the future of precision medicine.
